Cardiovascular Disease Doctors in Wilmington, OH Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Raja A. Nazir, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 630 W Main St Ste 105, Wilmington, OH 45177 Phone: 937-283-9888

Christopher M Wright, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 W Locust St Ste 300, Wilmington, OH 45177 Phone: 937-382-2785    Fax: 937-382-0504

Dr. James Edward Schmidt, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 630 W Main St Ste 105, Wilmington, OH 45177 Phone: 937-283-9888    Fax: 937-283-9892

Hassan F Hamed, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 W Locust St Ste 300, Wilmington, OH 45177 Phone: 937-382-2785    Fax: 937-382-0504

Dr. M. Niranjan Reddy, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 630 W Main St Ste 105, Wilmington, OH 45177 Phone: 937-283-9888

News Archive

Wall Street Journal examines India's public health infrastructure

The Wall Street Journal and the newspaper's "India Real Time" blog published stories on Saturday examining India's health care system. "Indian government officials say the country's public health infrastructure is sorely deficient, but they argue it is improving because of several initiatives underway," the blog reports.

InterStim Therapy now available for treatment of chronic bowel incontinence

A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function.

Experts counter study's claim - men should continue prostate exams

A man has a one in six chance of being diagnosed with prostate cancer. Each year, more than 230,000 men are diagnosed with the disease. Doctors have traditionally recommended two tests for the early detection of prostate cancer; the prostate specific antigen (PSA) test and digital rectal exam (DRE) are used to detect abnormalities with the prostate gland.

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

Singularity University, a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to tackle the world's greatest challenges, and BD (Becton, Dickinson and Company), a leading global medical technology company, have established a collaborative relationship where BD will leverage SU's expertise, innovation space, tools and inspiration to create new growth opportunities for healthcare and BD.

European Patent Office grants ProtAffin key patent for CellJammer discovery technology

ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.

Read more Medical News

› Verified 6 days ago